157 related articles for article (PubMed ID: 11004691)
1. Expression of oestrogen receptor alpha variants in non-malignant breast and early invasive breast carcinomas.
Chappell SA; Johnson SM; Shaw JA; Walker RA
J Pathol; 2000 Oct; 192(2):159-65. PubMed ID: 11004691
[TBL] [Abstract][Full Text] [Related]
2. Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas.
Shaw JA; Udokang K; Mosquera JM; Chauhan H; Jones JL; Walker RA
J Pathol; 2002 Dec; 198(4):450-7. PubMed ID: 12434414
[TBL] [Abstract][Full Text] [Related]
3. Identification of wild type and variants of oestrogen receptors in polymorphonuclear and mononuclear leucocytes.
Stygar D; Westlund P; Eriksson H; Sahlin L
Clin Endocrinol (Oxf); 2006 Jan; 64(1):74-81. PubMed ID: 16402932
[TBL] [Abstract][Full Text] [Related]
4. Oestrogen receptor expression in the normal and pre-cancerous breast.
Shoker BS; Jarvis C; Sibson DR; Walker C; Sloane JP
J Pathol; 1999 Jul; 188(3):237-44. PubMed ID: 10419589
[TBL] [Abstract][Full Text] [Related]
5. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
6. Expression of estrogen receptor alpha exon-deleted mRNA variants in the human and non-human primate frontal cortex.
Perlman WR; Matsumoto M; Beltaifa S; Hyde TM; Saunders RC; Webster MJ; Rubinow DR; Kleinman JE; Weickert CS
Neuroscience; 2005; 134(1):81-95. PubMed ID: 15964702
[TBL] [Abstract][Full Text] [Related]
7. Distinct expression of Survivin splice variants in breast carcinomas.
Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
[TBL] [Abstract][Full Text] [Related]
8. PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma.
Buttitta F; Felicioni L; Barassi F; Martella C; Paolizzi D; Fresu G; Salvatore S; Cuccurullo F; Mezzetti A; Campani D; Marchetti A
J Pathol; 2006 Feb; 208(3):350-5. PubMed ID: 16353168
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor mRNA splice variants in pre- and postmenopausal human endometrium and endometrial carcinoma.
Rice LW; Jazaeri AA; Shupnik MA
Gynecol Oncol; 1997 Apr; 65(1):149-57. PubMed ID: 9103405
[TBL] [Abstract][Full Text] [Related]
10. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
11. Differences in estrogen receptor alpha variant messenger RNAs between normal human breast tissue and primary breast carcinomas.
van Dijk MA; Hart AA; van 't Veer LJ
Cancer Res; 2000 Feb; 60(3):530-3. PubMed ID: 10676630
[TBL] [Abstract][Full Text] [Related]
12. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry].
Masiuk M
Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394
[TBL] [Abstract][Full Text] [Related]
13. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue.
Happerfield LC; Miles DW; Barnes DM; Thomsen LL; Smith P; Hanby A
J Pathol; 1997 Dec; 183(4):412-7. PubMed ID: 9496257
[TBL] [Abstract][Full Text] [Related]
14. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.
Girault I; Lerebours F; Amarir S; Tozlu S; Tubiana-Hulin M; Lidereau R; Bièche I
Clin Cancer Res; 2003 Apr; 9(4):1259-66. PubMed ID: 12684393
[TBL] [Abstract][Full Text] [Related]
15. No hypersensitive estrogen receptor-alpha mutation (K303R) in Japanese breast carcinomas.
Tokunaga E; Kimura Y; Maehara Y
Breast Cancer Res Treat; 2004 Apr; 84(3):289-92. PubMed ID: 15026626
[TBL] [Abstract][Full Text] [Related]
16. Expression of estrogen receptor variant messenger RNAs and determination of estrogen receptor status in human breast cancer.
Huang A; Leygue ER; Snell L; Murphy LC; Watson PH
Am J Pathol; 1997 May; 150(5):1827-33. PubMed ID: 9137105
[TBL] [Abstract][Full Text] [Related]
17. Expression of c-kit protein in proliferative lesions of human breast: sexual difference and close association with phosphotyrosine status.
Tsuura Y; Suzuki T; Honma K; Sano M
J Cancer Res Clin Oncol; 2002 May; 128(5):239-46. PubMed ID: 12029439
[TBL] [Abstract][Full Text] [Related]
18. Novel transcripts of the estrogen receptor alpha gene in channel catfish.
Patiño R; Xia Z; Gale WL; Wu C; Maule AG; Chang X
Gen Comp Endocrinol; 2000 Dec; 120(3):314-25. PubMed ID: 11121296
[TBL] [Abstract][Full Text] [Related]
19. First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.
Helms MW; Packeisen J; August C; Schittek B; Boecker W; Brandt BH; Buerger H
J Pathol; 2005 Jul; 206(3):366-76. PubMed ID: 15892165
[TBL] [Abstract][Full Text] [Related]
20. Oestrogen receptor-alpha variant mRNA expression in primary human breast tumours and matched lymph node metastases.
Leygue E; Hall RE; Dotzlaw H; Watson PH; Murphy LC
Br J Cancer; 1999 Feb; 79(5-6):978-83. PubMed ID: 10070900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]